CMPX logo

Compass Therapeutics (CMPX) EBITDA

Annual EBITDA

-$54.87 M
-$6.40 M-13.20%

December 1, 2024


Summary


Performance

CMPX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMPXprofitabilitymetrics:

Quarterly EBITDA

-$16.21 M
-$4.44 M-37.72%

December 1, 2024


Summary


Performance

CMPX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMPXprofitabilitymetrics:

TTM EBITDA

-$54.88 M
-$1.29 M-2.41%

December 1, 2024


Summary


Performance

CMPX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMPXprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CMPX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.2%-31.8%-6.4%
3 y3 years+31.6%-31.8%-6.4%
5 y5 years-75.3%-31.8%-6.4%

CMPX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-38.0%+31.6%-140.3%at low-64.9%+31.5%
5 y5-year-109.8%+31.6%-233.5%+70.7%-128.8%+31.6%
alltimeall time-109.8%+31.6%-233.5%+70.7%-548.0%+31.6%

Compass Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$54.87 M(+13.2%)
-$16.21 M(+37.7%)
-$54.88 M(+2.4%)
Sep 2024
-
-$11.77 M(-19.2%)
-$53.59 M(+0.6%)
Jun 2024
-
-$14.58 M(+18.5%)
-$53.27 M(+3.3%)
Mar 2024
-
-$12.31 M(-17.5%)
-$51.55 M(+6.3%)
Dec 2023
-$48.47 M(+21.9%)
-$14.93 M(+30.2%)
-$48.48 M(+5.5%)
Sep 2023
-
-$11.46 M(-10.9%)
-$45.96 M(-1.4%)
Jun 2023
-
-$12.86 M(+39.3%)
-$46.61 M(+10.4%)
Mar 2023
-
-$9.23 M(-25.6%)
-$42.23 M(+6.2%)
Dec 2022
-$39.75 M(-50.4%)
-$12.40 M(+2.4%)
-$39.75 M(-0.4%)
Sep 2022
-
-$12.11 M(+42.7%)
-$39.91 M(+19.9%)
Jun 2022
-
-$8.49 M(+25.8%)
-$33.29 M(-58.4%)
Mar 2022
-
-$6.75 M
-$80.07 M
DateAnnualQuarterlyTTM
Dec 2021
-$80.19 M(+206.6%)
-
-
Dec 2021
-
-$12.56 M(+128.7%)
-$80.19 M(+7.2%)
Sep 2021
-
-$5.49 M(-90.1%)
-$74.77 M(-3.9%)
Jun 2021
-
-$55.27 M(+704.9%)
-$77.78 M(+184.1%)
Mar 2021
-
-$6.87 M(-3.9%)
-$27.38 M(+4.7%)
Dec 2020
-$26.16 M(-16.4%)
-$7.14 M(-16.0%)
-$26.16 M(+5.4%)
Sep 2020
-
-$8.50 M(+74.9%)
-$24.81 M(+3.5%)
Jun 2020
-
-$4.86 M(-13.9%)
-$23.98 M(-13.1%)
Mar 2020
-
-$5.65 M(-2.6%)
-$27.59 M(+25.7%)
Dec 2019
-$31.30 M(-11.8%)
-$5.80 M(-24.5%)
-$21.94 M(+35.9%)
Sep 2019
-
-$7.67 M(-9.4%)
-$16.14 M(+90.6%)
Jun 2019
-
-$8.47 M
-$8.47 M
Dec 2018
-$35.49 M
-
-

FAQ

  • What is Compass Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Compass Therapeutics?
  • What is Compass Therapeutics annual EBITDA year-on-year change?
  • What is Compass Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Compass Therapeutics?
  • What is Compass Therapeutics quarterly EBITDA year-on-year change?
  • What is Compass Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Compass Therapeutics?
  • What is Compass Therapeutics TTM EBITDA year-on-year change?

What is Compass Therapeutics annual EBITDA?

The current annual EBITDA of CMPX is -$54.87 M

What is the all time high annual EBITDA for Compass Therapeutics?

Compass Therapeutics all-time high annual EBITDA is -$26.16 M

What is Compass Therapeutics annual EBITDA year-on-year change?

Over the past year, CMPX annual EBITDA has changed by -$6.40 M (-13.20%)

What is Compass Therapeutics quarterly EBITDA?

The current quarterly EBITDA of CMPX is -$16.21 M

What is the all time high quarterly EBITDA for Compass Therapeutics?

Compass Therapeutics all-time high quarterly EBITDA is -$4.86 M

What is Compass Therapeutics quarterly EBITDA year-on-year change?

Over the past year, CMPX quarterly EBITDA has changed by -$3.91 M (-31.75%)

What is Compass Therapeutics TTM EBITDA?

The current TTM EBITDA of CMPX is -$54.88 M

What is the all time high TTM EBITDA for Compass Therapeutics?

Compass Therapeutics all-time high TTM EBITDA is -$8.47 M

What is Compass Therapeutics TTM EBITDA year-on-year change?

Over the past year, CMPX TTM EBITDA has changed by -$3.32 M (-6.44%)